Clinical Trial Detail

NCT ID NCT02100891
Title Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Monica Thakar
Indications

malignant glioma

astrocytoma

central nervous system germ cell tumor

Ewing sarcoma

osteosarcoma

medulloblastoma

rhabdomyosarcoma

malignant ependymoma

neuroblastoma

atypical teratoid rhabdoid tumor

Therapies
Age Groups: senior child

No variant requirements are available.